Zobrazeno 1 - 10
of 141
pro vyhledávání: '"James A Gossage"'
Autor:
Lauren A. Beslow, Helen Kim, Steven W. Hetts, Felix Ratjen, Marianne S. Clancy, James R. Gossage, Marie E. Faughnan
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 19, Iss 1, Pp 1-10 (2024)
Abstract Background Patients with hereditary hemorrhagic telangiectasia (HHT) are at risk for organ vascular malformations including arteriovenous malformations (AVMs) in the brain and lungs. North American HHT Centers of Excellence (CoEs) routinely
Externí odkaz:
https://doaj.org/article/d2c001a9ce01474883e4b78caae6578b
Autor:
Hanny Al-Samkari, Raj S. Kasthuri, Joseph G. Parambil, Hasan A. Albitar, Yahya A. Almodallal, Carolina Vázquez, Marcelo M. Serra, Sophie Dupuis-Girod, Craig B. Wilsen, Justin P. McWilliams, Evan H. Fountain, James R. Gossage, Clifford R. Weiss, Muhammad A. Latif, Assaf Issachar, Meir Mei-Zahav, Mary E. Meek, Miles Conrad, Josanna Rodriguez-Lopez, David J. Kuter, Vivek N. Iyer
Publikováno v:
Haematologica, Vol 106, Iss 8 (2020)
Hereditary hemorrhagic telangiectasia (HHT, Osler-Weber-Rendu disease) is a rare multisystem vascular disorder causing chronic gastrointestinal bleeding, epistaxis, and severe anemia. Bevacizumab, an anti-vascular endothelial growth factor antibody,
Externí odkaz:
https://doaj.org/article/5212c2e98ac741cb90e807f30327a909
Autor:
Theodora Ananiadis, Marie E. Faughnan, Dewi Clark, Vikram Prabhudesai, Helen Kim, Michael T. Lawton, Nicholas T. Vozoris, Murali Chakinala, Marianne S. Clancy, James R. Gossage, Steven W. Hetts, Vivek Iyer, Raj S. Kasthuri, Timo Krings, Doris Lin, Hans-Jurgen Mager, Douglas A. Marchuk, Justin P. McWilliams, Jamie McDonald, Ludmila Pawlikowska, Jeffrey Pollak, Felix Ratjen, Karen Swanson, Dilini Vethanayagam, Shantel Weinsheimer, Andrew J. White, Pearce Wilcox
Publikováno v:
Annals of the American Thoracic Society. 19:1432-1435
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4f8a434fc6c6370e995489368651f75
https://doi.org/10.1513/annalsats.202202-130rl
https://doi.org/10.1513/annalsats.202202-130rl
Autor:
Group, Alexandra Kilian, Giuseppe A. Latino, Andrew J. White, Felix Ratjen, Jamie McDonald, Kevin J. Whitehead, James R. Gossage, Timo Krings, Michael T. Lawton, Helen Kim, Marie E. Faughnan, The Brain Vascular Malformation Consortium HHT Investigator Group The Brain Vascular Malformation Consortium HHT Investigator
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 7; Pages: 2704
Hereditary hemorrhagic telangiectasia (HHT) is a rare autosomal dominant disease characterized by the development of vascular malformations (VMs) in organs such as the brain and lungs, as well as telangiectases on mucosal surfaces. Prophylactic treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::cd029d610c6db36868470c927022d97e
Publikováno v:
Annals of Esophagus.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a275cf74a0e52762de811d1fd55d2d10
https://doi.org/10.21037/aoe-22-29
https://doi.org/10.21037/aoe-22-29
Autor:
Ricardo McEwen, James A. Gossage, Gincy George, Naami Mcaddy, J Zylstra, Jesper Lagergren, Nyree Griffin, R Bott, William R. C. Knight, Mieke Van Hemelrijck, Mark Kelly, Nick Maisey, Andrew Davies, Cara R. Baker
Publikováno v:
Acta Oncologica. 60:1629-1636
BACKGROUND Neoadjuvant chemotherapy is often used prior to surgical resection for oesophageal adenocarcinoma but remains ineffective in a high proportion of patients. The histological Mandard tumour regression grade is used to determine chemoresponse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::486f9db4c983114e2c391b47ac72a6b8
https://doi.org/10.1080/0284186x.2021.1986228
https://doi.org/10.1080/0284186x.2021.1986228
Publikováno v:
BJS Open. 6
Background The literature lacks robust evidence comparing definitive chemoradiotherapy (dCRT) with neoadjuvant chemoradiotherapy and surgery (nCRS) for oesophageal squamous cell carcinoma (ESCC). This study aimed to compare long-term survival of thes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9162fda182ee06448f462a8f36899d04
https://doi.org/10.1093/bjsopen/zrac125
https://doi.org/10.1093/bjsopen/zrac125
Autor:
Jonathan Moore, Michael Green, Mieke Van Hemelrijck, Harriet Deere, Richard PT Evans, Mona Elshafie, Anita Lavery, Andrew McGuigan, Rosalie Douglas, Damian Mcmanus, Joanne Horne, Robert Walker, Hira Mir, Monica Terlizzo, Sivesh K Kamarajah, Aida Santaolalla, Nick Maisey, Ailsa Lumsden, Sarah Ngan, Mark Kelly, Cara R Baker, Sacheen Kumar, Jesper Lagergren, William H Allum, James A Gossage, Ewan Griffiths, Heike I Grabsch, Richard C Turkington, Tim Underwood, Elizabeth Smyth, Rebecca Fitzgerald, David Cunningham, Andrew R Davies
Publikováno v:
Diseases of the Esophagus. 35
The prognostic benefit of primary tumour and lymph node (LN) downstaging after neoadjuvant chemotherapy for oesophageal adenocarcinoma (OAC) is well described. However, there is no robust evidence regarding the prognostic effect of pathological LN re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::602aeffdd4bd4ae3ec05750bd8d313b3
https://doi.org/10.1093/dote/doac051.568
https://doi.org/10.1093/dote/doac051.568
Autor:
Jonathan Moore, Manil Subesinghe, Aida Santaolalla, Michael Green, Harriet Deere, Mieke Van Hemelrijck, Jesper Lagergren, Sugama Chicklore, Nick Maisey, Mark Kelly, James A Gossage, Cara R Baker, Andrew R Davies
Publikováno v:
Diseases of the Esophagus. 35
2-deoxy-2[18F]fluoro-D-glucose positron emission tomography-computed tomography (FDG-PET-CT) is routinely used for staging of oesophageal cancer and has an emerging role in assessing response to neoadjuvant therapy. The primary aim of this study was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f8a68220ef8604400e05e2b957c1939b
https://doi.org/10.1093/dote/doac051.577
https://doi.org/10.1093/dote/doac051.577
Autor:
J Zylstra, Nick Maisey, Cara R. Baker, Daniel M. Foley, Jesper Lagergren, Mohamed Saad Aboul-Enein, William R. C. Knight, Elizabeth C Smyth, Mark Kelly, Andrew Davies, James A. Gossage, David Cunningham, Wahyu Wulaningsih, Dionysios Dellaportas, William H. Allum
Publikováno v:
Journal of Surgical Oncology. 124:1296-1305
BACKGROUND Most patients presenting with oesophageal cancer do so with advanced disease not suitable for surgery. However, there are examples of encouraging survival following surgery in highly selected patients who respond well to chemotherapy. METH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14890e7ccba58b63fdd134cff941611e
https://doi.org/10.1002/jso.26648
https://doi.org/10.1002/jso.26648